PECULIARITIES OF THE COURSE OF VEGETATIVE DISORDERS IN PATIENTS WHO ARE ON PROGRAM HEMODIALYSIS, TAKING INTO ACCOUNT THE PRESENCE OF TYPE 2 DIABETES

Authors

  • S. T. Rustamian Ukrainian Medical Stomatological Academy, Poltava
  • I. P. Katerenchuk Ukrainian Medical Stomatological Academy, Poltava

DOI:

https://doi.org/10.11603/1811-2471.2020.v.i2.11335

Keywords:

hemodialysis, renal failure, autonomic disorders

Abstract

The aim – to conduct a comparative analysis of clinical manifestations of autonomic disorders in patients undergoing programmed hemodialysis, taking into account the presence of type 2 diabetes mellitus.

Material and Methods. The study involved 93 patients who were treated in 2019 at the Center for Nephrology and Dialysis, Poltava. Depending on the stage of CKD, two groups of patients were identified – 44 patients (47.3 %) on program hemodialysis (experimental group – ЕG) and 49 patients (52.7 %) with CKD stage I–II (control group – CG), in each of which patients were stratified into two subgroups: with the presence of type 2 diabetes mellitus (DM) and without diabetes: ЕG 20 and 24 patients, CG 26 and 23, respectively. A questionnaire AM Wayne was used to identify signs of autonomic disorders. Autonomic dysfunction occurred when the total score exceeded 15. Statistical analysis was performed using Microsoft Excel software, using statistical calculation options (standard deviation, arithmetic mean, standard error). The probability of differences between the comparison groups was determined using the parametric Student’s test.

Results and Discussion. According to the results of questionnaires of patients according to the standardized questionnaire A.M. Wayne found that in patients on program hemodialysis with diabetes in the set of responses of patients signs of autonomic disorders were evaluated (46.1±9.1) points at minimum-maximum values (19–58), then as in the control group with diabetes (11.4±3.1) points, at the minimum-maximum values (7–18), p<0.001. The same value was obtained when comparing ЕG without diabetes (34.8±4.6) points, at the minimum-maximum values (17–43) and CG without diabetes (9.4±2.5) points, at the minimum-maximum values (7–15), p<0.001. The incidence of autonomic dysfunction in EG with diabetes and EG without diabetes did not have a statistically significant difference (p>0.05), but the autonomic dysfunction in the groups differed in structure.

Conclusions. Manifestations of autonomic dysfunction in patients with chronic kidney disease with type 2 diabetes differ in structure from the manifestations in patients with chronic kidney disease without diabetes. With the increase in the stage of chronic kidney disease in patients with diabetes and without diabetes, there was an increase in the manifestations of autonomic dysfunction, which are not eliminated by hemodialysis sessions.

References

(2018). Bulletin of the World Health Organization, 96, 414-422D. DOI: http://dx.doi.org/10.2471/BLT.17.206441 DOI: https://doi.org/10.2471/BLT.17.206441

Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., & Carter, A., et al. (2016). Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388 (10053), 1459-544.

Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H.M., & Okpechi, I., et al. (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet, 385 (9981), 1975-1982.

Mehta, R.L., Cerdá, J., Burdmann, E.A., Tonelli, M., García-García, G., & Jha, V., et al. (2015). International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, 385 (9987), 2616-2643.

Obinna Onodugo, Ejikeme Arodiwe, Julius Okoye, Birinus Ezeala, Nkiru Onodugo, Ifeoma Ulasi, & Chinwuba Ijoma (2018). Prevalence of autonomic dysfunction among pre-dialysis chronic kidney disease patients in a tertiary hospital. South East Nigeria Afr. Health Sci., 18 (4), 950-957. DOI: 10.4314/ahs.v18i4.14 DOI: https://doi.org/10.4314/ahs.v18i4.14

Israel dos Reis Santos, Aline Roberta Danaga, Isabella de Carvalho Aguiar, Ezequiel Fernandes Oliveira, Ismael Souza Dias, Jessica Julioti Urbano, & Aline Almeida Martins, et.al. (2013). Cardiovascular risk and mortality in end-stage renal disease patients undergoing dialysis: sleep study, pulmonary function, respiratory mechanics, upper airway collapsibility, autonomic nervous activity, depression, anxiety, stress and quality of life: a prospective, double blind, randomized controlled clinical trial. BMC Nephrol., 14, 215. Published online 2013 Oct 8. DOI: 10.1186/1471-2369-14-215 DOI: https://doi.org/10.1186/1471-2369-14-215

Reulecke, S., Schulz, S., & Voss, A. (2012). Autonomic regulation during quiet and active sleep states in very preterm neonates. Front. Physiol., 3, 61. 10.3389/fphys.2012.00061 DOI: https://doi.org/10.3389/fphys.2012.00061

Vein, A.M. (Ed.). (1998). Vegetativnye rasstroystva. Klinika, diagnostika, lechenie [Autonomic disorders. Clinic, diagnosis, treatment]. Moscow: Meditsina [in Russian]

Published

2020-08-19

How to Cite

Rustamian, S. T., & Katerenchuk, I. P. (2020). PECULIARITIES OF THE COURSE OF VEGETATIVE DISORDERS IN PATIENTS WHO ARE ON PROGRAM HEMODIALYSIS, TAKING INTO ACCOUNT THE PRESENCE OF TYPE 2 DIABETES. Achievements of Clinical and Experimental Medicine, (2), 156–160. https://doi.org/10.11603/1811-2471.2020.v.i2.11335

Issue

Section

Оригінальні дослідження